News » Resounding success at the EPO for Biotech team

Resounding success at the EPO for Biotech team

News 28 November 2016

Matthew Spencer and James Legg, representing Adaptive Biotechnologies Corporation, successfully defended European Patent No. 2 364 368 at the European opposition hearing on 16 November 2016.

The Patent, which had been opposed by three opponents, provides broad protection for immune profiling using next-generation sequencing (NGS).

Adaptive Biotechnologies Corporation is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. Its platforms include immunoSEQ®, a research-based assay, and clonoSEQ®, a diagnostic assay for the monitoring of patients with lymphoid cancers.

Relevant sectors

Aerospace

Commercial aviation
Defence and security
Space and satellites
Unmanned aerial vehicles

Artificial Intelligence and Machine Learning

Automotive

Autonomous vehicles
Electric vehicles
Engines

Biotechnology

Antibody engineering
Antibody manufacture and formulation
Bioinformatics
Biosimilars
Drug delivery
Gene editing (e.g. CRISPR)
Genomic and molecular tools and methods
GM crops
Immuno-oncology (e.g. checkpoint inhibitors; modified T cells)
Next generation sequencing
Nucleic acid synthesis
Personalised medicine/disease biomarkers
Recombinant protein production and purification
Stem cell therapies
Supplementary protection certificates (SPCs)
Synthetic biology
Therapeutic antibodies
Vaccinology (e.g. viral vectors; mRNA vaccines)
Women’s health products

Chemicals

Agrochemicals
Catalysts
Dispersions and colloids
Lubricants
Polymers and plastics

Communications and Networks

Cloud computing
Internet of things (IOT)
Oceanography, marine
Wired and wireless networks

Computing and Software

Artificial intelligence and machine learning
Bioinformatics
Blockchain and distributed ledgers
Communications and networks
Computer games
Data and software security, cryptography and digital rights management (DRM)
Data management and storage, databases and data compression
Digital assistants, virtual assistants and software agents
Fintech and adtech
Machine vision
Metaverse, virtual reality (VR) and augmented reality (AR)
Motor capture
Multimedia, audio/video processing and animation
Natural language processing
Quantum computing
Robotic process automation
Search engines
Signal processing
Software applications and systems, mobile applications, user interfaces

Consumer Goods and Retail

Anti-counterfeit devices
Beauty
Fashion
Health, fitness and sport
Household goods
Luxury goods
Moda
Retail

Electronics and Electrical Devices

Computer and IT architecture and system design
Medical devices
Optics
Restaurants and bars
Robotics
Scientific instruments
Semiconductor devices
Testing systems, control systems, signal processing
Travel and leisure
Wearable tech and human interfaces

Energy and Green Technologies

Biofuels
Clean air
Fuel cells and battery technology
Renewables and recycling
Solar power
Water, oil and gas, nuclear, fusion, fission
Wind turbines

Food and Beverage

Beverages
Nutrition
Retail

Industrial Manufacturing and Processing

Packaging
Polymers and plastics
Printing tech
Additive manufacturing
Coatings
Construction

Materials

Advanced materials
Composite materials
Metallurgy and alloys
Nanotechnology

Medical Devices and Diagnostics

Artificial intelligence
Devices
Diagnostic instruments
Digital health
Drug delivery
Immuno-oncology
In vitro diagnostics
Medtech

Pharmaceuticals

Diagnostics
Drug delivery
Generic market entry
Medicinal chemistry
Methods of production and synthesis
Personalised medicine/disease biomarkers
Pharmaceutical formulations
Pharmaceuticalsceutical formulations
Polymorphs
Small molecule pharmaceuticals
Supplementary protection certificates (SPCs)

Trade Marks

Consumer goods
Cosmetics and perfumery
Financial services
Mechanical engineering
Mechanical products
Services
Telecommunications